Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CA/Palmdale
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Palmdale, CA

Studies commonly pay $75 to $4,500 per completed study

129 clinical trials are currently recruiting participants within 30 miles of Palmdale. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

129studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Palmdale right now

Top 25 of 129 recruiting studies, sorted by proximity — each links to its official registry page

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

Lupus Nephritis Phase 2 Interventional 240 participants sought
Olive View UCLA Medical Center — Sylmar, California (27.8 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT05268289)

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

Healthy Phase 3 Interventional 6,000 participants sought
Antelope Valley Medical Center — Lancaster, California (7.4 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07160244)

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis Phase 3 Interventional 2,150 participants sought
Akero Clinical Study Site — Lancaster, California (7.4 mi) · Sponsor: Akero Therapeutics, Inc
See eligibility & contact on ClinicalTrials.gov (NCT06528314)

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Metabolic Dysfunction-Associated Steatotic Liver Disease Phase 3 Interventional 4,500 participants sought
Om Research LLC — Lancaster, California (7.4 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07165028)

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Diabetes Mellitus, Type 2, Hypertension Phase 3 Interventional 11,800 participants sought
First Valley Medical Group — Lancaster, California (7.4 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07064473)

A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo

Vitiligo, Non-Segmental Vitiligo (NSV) Phase 2 Interventional 66 participants sought
Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway — Santa Clarita, California (28.6 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07533019)

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Metabolic Dysfunction-Associated SteatoHepatitis (MASH) Phase 2 Interventional 120 participants sought
Om Research Llc — Lancaster, California (7.4 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT05519475)

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Moderately to Severely Active Crohns Disease Phase 3 Interventional 600 participants sought
Gastro Care Associates — Lancaster, California (7.4 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06819878)

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Phase 3 Interventional 3,680 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06058377)

Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference

Colonic Polyps N/A Interventional 330 participants sought
Gastro Care Institute — Lancaster, California (7.4 mi) · Sponsor: Capso Vision, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07089615)

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Diabetic Kidney Disease (DKD) Phase 2 Interventional 195 participants sought
Amicis Research Center — Santa Clarita, California (28.6 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07271186)

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

Uterine Fibroids, Endometriosis Phase 3 Interventional 1,000 participants sought
San Fernando — San Fernando, California (28.8 mi) · Sponsor: Sumitomo Pharma Switzerland GmbH
See eligibility & contact on ClinicalTrials.gov (NCT05862272)

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

Ulcerative Colitis Phase 2 Interventional 99 participants sought
Investigational Site Number: 8400006 — Lancaster, California (7.4 mi) · Sponsor: Sanofi
See eligibility & contact on ClinicalTrials.gov (NCT06975722)

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma Phase 3 Interventional 336 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07061977)

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Crohn Disease Phase 2, Phase 3 Interventional 1,092 participants sought
Om Research, LLC 1 — Lancaster, California (7.4 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07196722)

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Moderately to Severely Active Crohns Disease Phase 3 Interventional 425 participants sought
Om Research LLC — Lancaster, California (7.4 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06819891)

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Ulcerative Colitis, Inflammatory Bowel Diseases Phase 2 Interventional 645 participants sought
Site 012 — Lancaster, California (7.4 mi) · Sponsor: Spyre Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07012395)

A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma

Severe Asthma Phase 2 Interventional 512 participants sought
Research site — Lancaster, California (7.4 mi) · Sponsor: Kinaset Therapeutics Inc
See eligibility & contact on ClinicalTrials.gov (NCT07532265)

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma Phase 2 Interventional 227 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05890352)

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

Acne Phase 1, Phase 2 Interventional 800 participants sought
Amicis Research Center, LLC- Site Number : 8400110 — Palmdale, California (1.2 mi) · Sponsor: Sanofi Pasteur, a Sanofi Company
See eligibility & contact on ClinicalTrials.gov (NCT06316297)

A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus Phase 4 Interventional 350 participants sought
GSK Investigational Site — Tujunga, California (25.8 mi) · Sponsor: GlaxoSmithKline
See eligibility & contact on ClinicalTrials.gov (NCT06411249)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06337318)
Actively enrolling

Studies you may be able to join near Palmdale

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Palmdale

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

C&C Market Research

★ 4.7
1233 Rancho Vista Blvd #505, Palmdale, CA 93551
(661) 575-0777
"Great place. Great people. Top secret!"
— Melissa Morch, 5★

Om Research Clinical Trials

★ 3.0
1601 W Ave J Fl 2, Lancaster, CA 93534
(661) 388-2239

Antelope Valley Clinical Trials

44453 16th St W Ste 101, Lancaster, CA 93534
(661) 266-8944

Research Center-Clinical

1314 W Ave J, Lancaster, CA 93534
(661) 726-1515

Clinical Research Group of Los Angeles

43700 17th St W, Lancaster, CA 93534

Chemidox Clinical Trials Inc.

★ 4.0
44404 16th St W Ste 101, Lancaster, CA 93534
(833) 324-3643
"Steven and Ailene and Stefany were all very helpful and professional. My experience with Chemidox was an enjoyable one. The staff was knowledgeable a…"
— Shawna Bullock, 5★

Long Beach Research Institute

★ 4.7
3300 E South St #205, Long Beach, CA 90805
(562) 471-3773
"Came here for a research study. Great place."
— Anthony Roberts, 5★

Clinical Research of California

★ 4.3
7301 Medical Center Dr Unit 405, West Hills, CA 91307

La Clinical Trials

★ 5.0
847 N Hollywood Way, Burbank, CA 91505
(818) 526-7645
"Eli is the bomb , never get stuck twice . He’s always on point . Thanks Eli and everybody working there ."
— Kevin Juengain, 5★

Clinical trials in Palmdale: what's recruiting

The Palmdale area currently has 129 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Palmdale, the most active research areas are:

  • Immune & Skin7 studies
  • Diabetes & Metabolism5 studies
  • Liver & Kidney4 studies
  • Cancer & Oncology4 studies
  • Lungs & Breathing2 studies

Every listing shows the study phase, the recruiting site and its distance from Palmdale, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Palmdale

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Palmdale participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Palmdale?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Palmdale safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Palmdale, CA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Palmdale?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Palmdale.

Paid clinical trials near Palmdale

Other metros within reach

Lancaster, CA105 Santa Clarita, CA2,384 Glendale, CA2,964 Los Angeles, CA2,949 Pomona, CA3,148 Rancho Cucamonga, CA1,489 Fullerton, CA3,251 Ontario, CA1,726

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Palmdale Bladder Issues Due To Spinal Cord Injury in Palmdale All conditions

More of CA

Long Beach3,366 Torrance3,258 Fullerton3,251 Anaheim3,193 Garden Grove3,186 Pomona3,148 Glendale2,964 Los Angeles2,949 Huntington Beach2,867 Santa Clarita2,384 Hayward2,257 Oakland2,248

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts